|
1
|
Macisaac RJ, Ekinci EI and Jerums G:
Markers of and risk factors for the development and progression of
diabetic kidney disease. Am J Kidney Dis. 63(Suppl 2): S39–S62.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Rizzo M, Obradovic M, Labudovic-Borovic M,
et al: Uric acid metabolism in pre-hypertension and the metabolic
syndrome. Curr Vasc Pharmacol. 12:572–585. 2014. View Article : Google Scholar
|
|
3
|
Johnson RJ, Nakagawa T, Sanchez-Lozada LG,
Shafiu M, Sundaram S, Le M, Ishimoto T, Sautin YY and Lanaspa MA:
Sugar, uric acid, and the etiology of diabetes and obesity.
Diabetes. 62:3307–3315. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zhou Y, Fang L, Jiang L, Wen P, Cao H, He
W, Dai C and Yang J: Uric acid induces renal inflammation via
activating tubular NF-κB signaling pathway. PLoS One. 7:e397382012.
View Article : Google Scholar
|
|
5
|
Kang DH, Nakagawa T, Feng L, Watanabe S,
Han L, Mazzali M, Truong L, Harris R and Johnson RJ: A role for
uric acid in the progression of renal disease. J Am Soc Nephrol.
13:2888–2897. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Liu-Bryan R, Scott P, Sydlaske A, Rose DM
and Terkeltaub R: Innate immunity conferred by Toll-like receptors
2 and 4 and myeloid differentiation factor 88 expression is pivotal
to monosodium urate monohydrate crystal-induced inflammation.
Arthritis Rheum. 52:2936–2946. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Rock KL, Kataoka H and Lai JJ: Uric acid
as a danger signal in gout and its comorbidities. Nat Rev
Rheumatol. 9:13–23. 2013. View Article : Google Scholar :
|
|
8
|
Ghaemi-Oskouie F and Shi Y: The role of
uric acid as an endogenous danger signal in immunity and
inflammation. Curr Rheumatol Rep. 13:160–166. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Grainger R, McLaughlin RJ, Harrison AA and
Harper JL: Hyperuricaemia elevates circulating CCL2 levels and
primes monocyte trafficking in subjects with inter-critical gout.
Rheumatology (Oxford). 52:1018–1021. 2013. View Article : Google Scholar
|
|
10
|
Pineda C, Amezcua-Guerra LM, Solano C,
Rodriguez-Henríquez P, Hernández-Díaz C, Vargas A, Hofmann F and
Gutiérrez M: Joint and tendon subclinical involvement suggestive of
gouty arthritis in asymptomatic hyperuricemia: an ultrasound
controlled study. Arthritis Res Ther. 13:R42011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kanellis J, Watanabe S, Li JH, et al: Uric
acid stimulates monocyte chemoattractant protein-1 production in
vascular smooth muscle cells via mitogen-activated protein kinase
and cyclooxygenase-2. Hypertension. 41:1287–1293. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kang DH, Park SK, Lee IK and Johnson RJ:
Uric acid-induced C-reactive protein expression: implication on
cell proliferation and nitric oxide production of human vascular
cells. J Am Soc Nephrol. 16:3553–3562. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sánchez-Lozada LG, Lanaspa MA,
Cristóbal-García M, García-Arroyo F, Soto V, Cruz-Robles D,
Nakagawa T, Yu MA, Kang DH and Johnson RJ: Uric acid-induced
endothelial dysfunction is associated with mitochondrial
alterations and decreased intracellular ATP concentrations. Nephron
Exp Nephrol. 121:e71–e78. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sautin YY, Nakagawa T, Zharikov S and
Johnson RJ: Adverse effects of the classic antioxidant uric acid in
adipocytes: NADPH oxidase-mediated oxidative/nitrosative stress. Am
J Physiol Cell Physiol. 293:C584–C596. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Albertoni G, Maquigussa E, Pessoa E,
Barreto JA, Borges F and Schor N: Soluble uric acid increases
intracellular calcium through an angiotensin II-dependent mechanism
in immortalized human mesangial cells. Exp Biol Med (Maywood).
235:825–832. 2010. View Article : Google Scholar
|
|
16
|
Convento MS, Pessoa E, Dalboni MA, Borges
FT and Schor N: Pro-inflammatory and oxidative effects of
noncrystalline uric acid in human mesangial cells: contribution to
hyperuricemic glomerular damage. Urol Res. 39:21–27. 2011.
View Article : Google Scholar
|
|
17
|
Borges FT, Dalboni MA, Michelacci YM and
Schor N: Noncrystalline uric acid inhibits proteoglycan and
glycosaminoglycan synthesis in distal tubular epithelial cells
(MDCK). Braz J Med Biol Res. 43:957–963. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Mazzali M, Hughes J, Kim YG, Jefferson JA,
Kang DH, Gordon KL, Lan HY, Kivlighn S and Johnson RJ: Elevated
uric acid increases blood pressure in the rat by a novel
crystal-independent mechanism. Hypertension. 38:1101–1106. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ficociello LH, Rosolowsky ET, Niewczas MA,
et al: High-normal serum uric acid increases risk of early
progressive renal function loss in type 1 diabetes: results of a
6-year follow-up. Diabetes Care. 33:1337–1343. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Imig JD and Ryan MJ: Immune and
inflammatory role in renal disease. Compr Physiol. 3:957–976.
2013.PubMed/NCBI
|
|
21
|
Webb R, Jeffries M and Sawalha AH: Uric
acid directly promotes human T-cell activation. Am J Med Sci.
337:23–27. 2009. View Article : Google Scholar
|
|
22
|
Shi Y, Mucsi AD and Ng G: Monosodium urate
crystals in inflammation and immunity. Immunol Rev. 233:203–217.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kanneganti TD, Ozören N, Body-Malapel M,
et al: Bacterial RNA and small antiviral compounds activate
caspase-1 through cryopyrin/Nalp3. Nature. 440:233–236. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Brough D and Rothwell NJ:
Caspase-1-dependent processing of pro-interleukin-1beta is
cytosolic and precedes cell death. J Cell Sci. 120:772–781. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Witkowska AM and Borawska MH: Soluble
intercellular adhesion molecule-1 (sICAM-1): an overview. Eur
Cytokine Netw. 15:91–98. 2004.PubMed/NCBI
|
|
26
|
Johnson RJ, Nakagawa T, Jalal D,
Sánchez-Lozada LG, Kang DH and Ritz E: Uric acid and chronic kidney
disease: which is chasing which. Nephrol Dial Transplant.
28:2221–2228. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ryu ES, Kim MJ, Shin HS, Jang YH, Choi HS,
Jo I, Johnson RJ and Kang DH: Uric acid-induced phenotypic
transition of renal tubular cells as a novel mechanism of chronic
kidney disease. Am J Physiol Renal Physiol. 304:F471–F480. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Yang Z, Xiaohua W, Lei J, Ruoyun T,
Mingxia X, Weichun H, Li F, Ping W and Junwei Y: Uric acid
increases fibronectin synthesis through upregulation of lysyl
oxidase expression in rat renal tubular epithelial cells. Am J
Physiol Renal Physiol. 299:F336–F346. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Quan H, Peng X, Liu S, Bo F, Yang L, Huang
Z, Li H, Chen X and Di W: Differentially expressed protein profile
of renal tubule cell stimulated by elevated uric acid using SILAC
coupled to LC-MS. Cell Physiol Biochem. 27:91–98. 2011.PubMed/NCBI
|
|
30
|
Han HJ, Lim MJ, Lee YJ, Lee JH, Yang IS
and Taub M: Uric acid inhibits renal proximal tubule cell
proliferation via at least two signaling pathways involving PKC,
MAPK, cPLA2, and NF-kappaB. Am J Physiol Renal Physiol.
292:F373–F381. 2007. View Article : Google Scholar
|
|
31
|
Chen W, Roncal-Jimenez C, Lanaspa M,
Gerard S, Chonchol M, Johnson RJ and Jalal D: Uric acid suppresses
1 alpha hydroxylase in vitro and in vivo. Metabolism. 63:150–160.
2014. View Article : Google Scholar
|
|
32
|
Hua S: Targeting sites of inflammation:
Intercellular adhesion molecule-1 as a target for novel
inflammatory therapies. Front Pharmacol. 4:1272013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Schiffrin EL: The immune system: role in
hypertension. Can J Cardiol. 29:543–548. 2013. View Article : Google Scholar
|
|
34
|
Schiffrin EL: Immune mechanisms in
hypertension and vascular injury. Clin Sci (Lond). 126:267–274.
2014. View Article : Google Scholar
|
|
35
|
Tsuboi N, Yoshikai Y, Matsuo S, Kikuchi T,
Iwami K, Nagai Y, Takeuchi O, Akira S and Matsuguchi T: Roles of
toll-like receptors in C-C chemokine production by renal tubular
epithelial cells. J Immunol. 169:2026–2033. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Hato T, El-Achkar TM and Dagher PC:
Sisters in arms: myeloid and tubular epithelial cells shape renal
innate immunity. Am J Physiol Renal Physiol. 304:F1243–F1251. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Newton K and Dixit VM: Signaling in innate
immunity and inflammation. Cold Spring Harb Perspect Biol. 4:42012.
View Article : Google Scholar
|
|
38
|
Sloane JA, Blitz D, Margolin Z and
Vartanian T: A clear and present danger: endogenous ligands of
Toll-like receptors. Neuromolecular Med. 12:149–163. 2010.
View Article : Google Scholar :
|
|
39
|
Cha JJ, Hyun YY, Lee MH, et al: Renal
protective effects of toll-like receptor 4 signaling blockade in
type 2 diabetic mice. Endocrinology. 154:2144–2155. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Lee IT, Shih RH, Lin CC, Chen JT and Yang
CM: Role of TLR4/NADPH oxidase/ROS-activated p38 MAPK in VCAM-1
expression induced by lipopolysaccharide in human renal mesangial
cells. Cell Commun Signal. 10:332012. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Lin M, Yiu WH, Wu HJ, Chan LY, Leung JC,
Au WS, Chan KW, Lai KN and Tang SC: Toll-like receptor 4 promotes
tubular inflammation in diabetic nephropathy. J Am Soc Nephrol.
23:86–102. 2012. View Article : Google Scholar :
|
|
42
|
Cheng A, Dong Y, Zhu F, Liu Y, Hou FF and
Nie J: AGE-LDL activates Toll like receptor 4 pathway and promotes
inflammatory cytokines production in renal tubular epithelial
cells. Int J Biol Sci. 9:94–107. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Qing YF, Zhang QB, Zhou JG and Jiang L:
Changes in toll-like receptor (TLR)4-NFκB-IL1β signaling in male
gout patients might be involved in the pathogenesis of primary
gouty arthritis. Rheumatol Int. 34:213–220. 2014. View Article : Google Scholar
|
|
44
|
Correa-Costa M, Braga TT, Semedo P, et al:
Pivotal role of Toll-like receptors 2 and 4, its adaptor molecule
MyD88, and inflammasome complex in experimental tubule-interstitial
nephritis. PLoS One. 6:e290042011. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Bergler T, Hoffmann U, Bergler E, Jung B,
Banas MC, Reinhold SW, Krämer BK and Banas B: Toll-like receptor 4
in experimental kidney transplantation: early mediator of
endogenous danger signals. Nephron Exp Nephrol. 121:e59–e70. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Anzai N and Endou H: Urate transporters:
an evolving field. Semin Nephrol. 31:400–409. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Cronstein BN and Terkeltaub R: The
inflammatory process of gout and its treatment. Arthritis Res Ther.
8(Suppl 1): S32006. View
Article : Google Scholar : PubMed/NCBI
|
|
48
|
van de Veerdonk FL and Netea MG: New
insights in the immunobiology of IL-1 family members. Front
Immunol. 4:1672013. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Manea M, Tati R, Karlsson J, Békássy ZD
and Karpman D: Biologically active ADAMTS13 is expressed in renal
tubular epithelial cells. Pediatr Nephrol. 25:87–96. 2010.
View Article : Google Scholar
|
|
50
|
Edye ME, Lopez-Castejon G, Allan SM and
Brough D: Acidosis drives damage-associated molecular pattern
(DAMP)-induced interleukin-1 secretion via a caspase-1-independent
pathway. J Biol Chem. 288:30485–30494. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Chen Z, Liu Y, Sun B, et al:
Polyhydroxylated metallofullerenols stimulate IL-1beta secretion of
macrophage through TLRs/MyD88/NF-κB pathway and NLRP3
inflammasome activation. Small. 10:2362–2372. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Palová-Jelínková L, Dáňová K, Drašarová H,
et al: Pepsin digest of wheat gliadin fraction increases production
of IL-1β via TLR4/MyD88/TRIF/MAPK/NF-κB signaling pathway and an
NLRP3 inflammasome activation. PloS One. 8:e624262013. View Article : Google Scholar
|
